fromAbove the Law2 months agoIntellectual property lawPatenting Privation (Part III): Empowering Revenge - Above the LawThe FDA's lifting of the shortage declaration has curtailed bulk sales of competing diabetes medications, impacting telehealth revenues significantly.
MedicinefromWIRED5 months agoThe Ozempic Shortage Is OverThe FDA has declared semaglutide no longer in shortage, affecting cheaper compounded versions and signaling significant market changes.
fromAbove the Law2 months agoIntellectual property lawPatenting Privation (Part III): Empowering Revenge - Above the Law
MedicinefromWIRED5 months agoThe Ozempic Shortage Is OverThe FDA has declared semaglutide no longer in shortage, affecting cheaper compounded versions and signaling significant market changes.
